First Solar, Inc.

First Solar is the leading US-based utility-scale solar panel manufacturer — vertically integrated CdTe (cadmium telluride) technology, protected by IRA-era policy and now the emerging Section 232 tariff framework. The equity is down 8% YTD and sits at 20% of its 52-week range despite fundamentals continuing to work.

• The operating story is unambiguous: Q1 revenue grew 24% year-over-year to $1.04B, prior quarters ran 9-80% with 40-46% gross margins and 32-36% operating margins — that's the compounder profile in a business supposedly at cycle-risk.
• The BMO Aug 27 upgrade to Outperform with a $263 target is the specific catalyst: BMO frames the post-Section-232 selloff as an overshoot, citing a tariff/MIP framework that could lift US module ASPs to $0.43-$0.44/watt for a sold-out FSLR through 2029 — the specific price mechanism supporting the FY27 EPS estimate of $24.
• The valuation is genuinely undemanding: at 18x trailing earnings and roughly 12x FY26 EPS ($17.69 consensus) with a 5.6% free-cash-flow yield, this is priced as if the tariff framework doesn't hold — the 21% 5-year EPS growth at ~11x forward is what long-only value investors are pointing to.
• The insider tape leans slightly negative: officer Dymbort sold $923K at $249, Sloan $28K, others — small clusters at prices well above the current $204 tape, which puts a small cap on near-term upside but doesn't invalidate the fundamentals.

The path if it works is an Oct 29 Q3 print keeping revenue above +20% year-over-year plus specific commentary on Section 232 tariff-framework implementation — the tape breaks the coil upward toward the BMO $263 target. What extends the drift is a Q3 with margin compression from Chinese module oversupply or a fresh class-action escalation (Bragar Eagel & Squire investigation Aug 25); that's when a stock at 20% of its 52-week range gives back to the year's lows around $170.